Skip to content
healthcare.dev

RELGAABI

NDC 58657-233, Gabapentin, capsule, from Method Pharmaceuticals, LLC.

Product NDC
58657-233
Status
Listed
Labeler
Method Pharmaceuticals, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204989
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58657-233 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN300 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
58657-233-0158657023301100 CAPSULE in 1 BOTTLE, PLASTIC (58657-233-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4cc6615b-5447-9c0e-e063-6394a90a2883
  • NADAC price for package 58657023301

    GET /v1/drugs/nadac/58657023301

Use it

Look up 58657-233 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58657-233 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58657-233. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.